[ad_1]
Rome, November 23, 2020 – The vaccine against Coronavirus developed byOxfor Universityre me AstraZeneca, in collaboration withIrbm from Pomezia, is “70% effective”. The AstraZeneca announcement reports an evaluation of two vaccine studies and represents one media on clinical tests performed in United Kingdom and in Brazil. In total, 20,000 volunteers participated. The British government has already ordered 100 million doses of the vaccine, enough to immunize 50 million people.
According to the BBC, the 70% figure for the effectiveness of one type of Dose is less than vaccines developed by Pfizer me Modern, which showed a virus protection of more than 90%. Moderna said its vaccine prevented 94.5 percent of study participants from getting sick, while Pfizer, working with German partner BioNTech, said its vaccine prevented 95 percent of symptomatic infections.
Compared to Pfizer and Moderna, the Oxford vaccine me AstraZeneca however it seems to be definitely cheaper, but not only. Not having to be frozen is too much easier to store (for example in the refrigerator) and therefore can be available anywhere in the world. AstraZeneca stated that there were no serious adverse health events and that the vaccine was well tolerated in both dose groups. There have been no serious cases of COVID-19 in the study and no participant was hospitalized. The vaccine was found to be 62% effective when given in two full doses, but when given in one and a half doses (half the initial dose, one dose after a month) the effectiveness is 90%, with maximum protection and tolerability for people. older.
AstraZeneca will submit the Covid vaccine data to global regulatory authorities for conditional or early approval of the vaccine. The company will also apply to the World Health Organization for emergency use to accelerate the path to vaccine availability in low-income countries. The full analysis of the interim results has been submitted for publication in a scientific journal.
Boris Johnson: “Exciting News”
The British Prime Minister, Boris johnson, called “incredibly exciting news about the Oxford vaccine, which was so effective in the trial” conducted by the pharmaceutical company AstraZeneca. “More security checks need to be done, but these results are fantastic,” Johnson wrote on Twitter, “congratulations to our brilliant scientists at the University of Oxford, AstraZeneca, and to all the volunteers involved in the trials.”
© All rights reserved
